| LVNC | Left ventricular non-compaction |
| DCM | Dilated cardiomyopathy |
| dLVNC | Dilated left ventricular non-compaction |
| LVEF | Left ventricular ejection fraction |
| LVEDD | Left ventricular end-diastolic diameter |
| PSM | Propensity score matching |
| HF | Heart failure |
| MACEs | Major adverse cardiovascular events |
| LGE | Late gadolinium enhancement |
| CMR | Cardiac magnetic resonance |
| ESC | European Society of Cardiology |
| ICD | Implantable cardioverter–defibrillator |
| PUMCH | Peking Union Medical College Hospital |
| NC/C | Ratio of noncompacted to compacted myocardial layer thickness |
| ECG | Electrocardiography |
| UCG | Echocardiography |
| BMI | Body mass index |
| NYHA | New York Heart Association |
| cTnI | Cardiac troponin I |
| NT-proBNP | N-terminal pro-B-type natriuretic peptide |
| IVS | Interventricular septal thickness |
| LVPW | Left ventricular posterior wall thickness |
| RVD | Right ventricular anteroposterior diameter |
| LAD | Left atrial anteroposterior diameter |
| LA | Left atrium |
| CRT | Cardiac resynchronization therapy |
| HR | Hazard ratio |
| CI | Confidence interval |
| LVESD | Left ventricular end-systolic diameter |
| LVFS | Left ventricular fraction of shortening |
| HGB | Hemoglobin |
| ALT | Alanine transaminase |
| Scr | Serum creatine |
| FBG | Fasting blood glucose |
| TC | Total cholesterol |
| TG | Triglycerides |
| HDL-C | High-density lipoprotein cholesterol |
| LDL-C | Low-density lipoprotein cholesterol |
| AF | Atrial fibrillation |
| LBBB | Left bundle branch block |
| LV | Left ventricular |
| MVR | Mitral regurgitation |
| ACEI | Angiotensin-converting enzyme inhibitor |
| ARB | Angiotensin II receptor antagonist |
| ARNI | Angiotensin receptor–neprilysin inhibitor |
| MRA | Mineralocorticoid receptor antagonist |
| SGLT2i | Sodium-glucose cotransporter 2 inhibitor |
| CRT-D | Cardiac resynchronization therapy defibrillator |
| PM | Pacemaker |
| CRT-P | Cardiac resynchronization therapy pacemaker |